Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Global X Uranium ETF (URA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs Global X Uranium ETF — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.63 (market cap $2.27B), while Global X Uranium ETF trades at $38.82 (market cap $5.48B). The key difference: Global X Uranium ETF is far larger — about 2.4× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, Global X Uranium ETF nearer its low. Which is the better fit depends on your goals.
| SLS | URA | |
|---|---|---|
Market Cap | $2.27B | $5.48B |
Volume | 4,179,659 | 5,287,170 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $15.46 | $61.81 |
52-Week Low | $1.39 | $37.52 |
Enterprise Value | $2.14B | — |
Typical Hold Time | — | 62 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
URA is trading at $38.58, down 3.38% today amid bearish technical signals. The ETF shows negative momentum with all 13 moving averages signaling sell. Recent news highlights nuclear energy's growth potential, including US-Saudi atomic deals and AI-driven power demand, though uranium miners face price volatility. The fund provides diversified exposure to uranium miners, utilities, and nuclear infrastructure companies.
Outlook remains cautiously optimistic given nuclear energy's structural growth drivers, but near-term pressure persists from uranium price fluctuations. Key risks include commodity volatility and regulatory uncertainty, while catalysts include government nuclear investments and AI power demand. The current technical weakness may present entry opportunities for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About Global X Uranium ETF
URA provides broad exposure to the global uranium industry and nuclear energy sector. Unlike pure-play mining funds, it includes companies involved in nuclear component production and infrastructure, with top 2026 holdings such as Cameco, Oklo, and Uranium Energy Corp.
Read more on URA →
